
The Richard T. Silver MD Myeloproliterative Neoplasm Center at Weill Cornell Medicine was established in 2013 with a $3.7 million gift from the Cancer Research & Treatment Fund (CR&T) in honor of Dr. Richard T. Silver, a world-renowned authority on myeloproliferative neoplasms, or MPNs, a group of diseases related to the excessive production of bone marrow cells. The translational research and treatment center brings cross-disciplinary expertise and cutting-edge methods to research and treat these rare blood cancers. The Silver MPN Center was officially dedicated in February 2014.